loading...

Fibromyalgia Rapid Screening Tool (FiRST)

Perrot S; Bouhassira D

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

Developed in 2010

Authors

Perrot S; Bouhassira D

Copyright
FiRST© Serge Perrot, Didier Bouhassira, REDAR, 2010. All rights reserved
Objective
Screening tool developed for the detection of fibromyalgia syndrome in patients with diffuse chronic pain
Therapeutic area
  • Nervous System Diseases
  • Musculoskeletal Diseases
Therapeutic indication

Fibromyalgia

Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for the UK
  • French for France
Bibliographic reference(s) of the original questionnaire

Perrot S, Bouhassira D, Fermanian J. Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST). Pain. 2010 Aug;150(2):250-6 (PubMed abstract)

Access this questionnaire

Please proceed below

Login SIGN up free

Contact and conditions of use

Authors

Perrot S; Bouhassira D

Prof. Serge Perrot
Service de Médecine Interne et Thérapeutique
INSERM  U987
Hôpital Hôtel Dieu
1 Place du Parvis Notre Dame
75004 PARIS
France
Phone: +33 1 42 34 84 49
E-mail: serge.perrot@htd.aphp.fr

Perrot Serge publications (PubMed)

    

Dr. Didier Bouhassira
INSERM U987
« Pathophysiology and Clinical Pharmacology of Pain »
Centre d’Evaluation et de Traitement de la Douleur
Hôpital Ambroise Paré
9, Avenue Charles de Gaulle
92100 Boulogne-Billancourt
France
Phone: +33 1 49 09 45 56
Fax: +33 1 49 09 44 35
E-mail: didier.bouhassira@inserm.fr

Bouhassira D publications (PubMed)

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Students, physicians, clinical practice, not-funded academic users

You may access the questionnaire and/or its available translations directly (see tutorial). Should you not see the Download button, please contact us.

Funded academic users, healthcare organizations, commercial users & IT companies

Fees may apply to your project. Submit your request (see tutorial). Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner.

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • English for the UK
  • French for France

Translations

The list of available translations is subject to constant changes and may not be exhaustive. It is provided for information only. Some recently produced translations may not be included in the list below yet. Please do check the status of available translations with Mapi Research Trust / the developers / copyright holders / distributors.

Also, the listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.

FiRST

Dutch for Belgium (Flemish)*
Dutch for the Netherlands*
English for the USA*
French for Belgium*
German for Germany
Greek for Greece*
Italian for Italy*
Portuguese for Portugal*
Russian for Russia*
Spanish for Spain*
Turkish for Turkey
Ukrainian for Ukraine
* Performed by Mapi/ICON

The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi/ICON Language Services

More information on translations

Bibliographic reference of the Turkish translation:

Celiker et al. Reliability and validity of the Turkish version of the fibromyalgia rapid screening tool (FiRST). J. Phys. Ther. Sci. 29:340–344, 2017 (Full text article)

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us